Quantum Cyber NV（QUCY）の財務QUCYQuantum Cyber NV

In the context of the broader market, QUCY competes directly with industry leaders such as MBOT and OKYO. With a market capitalization of $62.00M, it holds a significant position in the sector. When comparing efficiency, QUCY's gross margin of N/A stands against MBOT's -266.80% and OKYO's N/A. Such benchmarking helps identify whether Quantum Cyber NV is trading at a premium or discount relative to its financial performance.

Mainz Biomed NV has shown troubling financials with a net income loss of $11,016,480 in Q2 2026 and a gross margin of 79.97% in Q3 2025, but revenues have been inconsistent, with zero revenue reported in recent quarters.